Skip to main content

Table 4 Estimated prevalence for each disease according to gender and age group

From: Prevalence of chronic diseases and morbidity in primary health care in central Greece: An epidemiological study

 

Male

Female

Total

 

< 65 years

≥65 years

Total

< 65 years

≥65 years

Total

 
 

N

Prevalence (95% CI)

N

Prevalence (95% CI)

N

Prevalence (95% CI)

N

Prevalence (95% CI)

N

Prevalence (95% CI)

N

Prevalence (95% CI)

 

A.General

460

1262.5 (1107.5 - 1417.5)

183

358.2 (250.5 - 465.9)

643

738.0 (617.1 - 859.0)

278

591.8 (522.2 - 661.5)

178

275.4 (214.6 - 336.2)

456

407.0 (353.9 - 460.0)

1099

B.Blood, lymphatics

31

85.8 (60.4 - 111.1)

119

246.7 (143.2 - 350.3)

150

173.1 (133.0 - 213.3)

124

256.4 (172.9 - 339.8)

212

322.2 (214.9 - 429.5)

336

292.9 (199.8 - 386.0)

486

C.Digestive

341

937.8 (804.4 - 1071.2)

431

822.9 (585.0 - 1060.7)

772

876.7 (701.1 - 1052.3)

398

859.1 (707.3 - 1010.8)

518

788.5 (582.0 - 995.0)

916

820.4 (642.7 - 998.2)

1688

F.Eye

89

238.8 (157.3 - 320.3)

117

231.1 (178.2 - 284.0)

206

233.1 (173.5 - 292.7)

56

119.0 (114.8 - 123.1)

189

282.0 (188.8 - 375.3)

245

215.2 (155.1 - 275.3)

451

H.Ear

58

155.5 (90.2 - 220.7)

31

66.6 (23.9 - 109.4)

89

105.0 (50.9 - 159.1)

78

158.4 (56.9 - 260.0)

40

61.9 (12.8 - 111.0)

118

104.7 (31.3 - 178.2)

207

K.Circulatory

715

1940.0 (1730.1 - 2149.9)

2445

4700.9 (4485.4 - 4916.4)

3160

3532.6 (3186.1 - 3879.1)

890

1892.2 (1494.8 - 2289.6)

2976

4344.2 (3959.3 - 4729.2)

3866

3311.7 (2775.2 - 3848.1)

7026

   Elevated blood pressure

389

1062.6 (868.6 - 1256.5)

1096

2105.5 (1743.4 - 2467.5)

1485

1665.3 (1362.0 - 1968.5)

589

1251.2 (1006.4 - 1496.0)

1645

2422.7 (2087.1 - 2758.2)

2234

1926.8 (1595.3 - 2258.4)

3719

   Coronary heart disease

225

608.7 (369.6 - 847.7)

959

1817.3 (1351.9 - 2282.6)

1184

1308.9 (890.7 - 1727.2)

179

380.8 (148.0 - 613.6)

958

1354.4 (946.4 - 1762.5)

1137

949.3 (562.4 - 1336.2)

2321

L.Musculoskeletal

416

1122.3 (1047.1 - 1197.5)

457

886.9 (826.0 - 947.8)

873

988.0 (926.4 - 1049.6)

795

1696.8 (1491.5 - 1902.0)

1482

2216.7 (2017.8 - 2415.6)

2277

1990.4 (1795.6 - 2185.3)

3150

   Osteoarthritis

60

163.3 (131.8 - 194.7)

121

234.5 (171.9 - 297.0)

181

203.1 (158.4 - 247.7)

145

315.4 (238.3 - 392.5)

358

537.7 (366.9 - 708.5)

503

447.2 (316.8 - 577.6)

684

   Osteoporosis

11

27.6 (0 - 55.7)

37

68.8 (36.3 - 101.3)

48

51.0 (20.3 - 81.7)

300

629.3 (499.4 - 759.3)

699

1014.4 (911.7 - 1117.1)

999

850.3 (712.8 - 987.8)

1047

N.Neurological

122

328.9 (284.5 - 373.2)

278

545.2 (426.0 - 664.5)

400

456.1 (393.7 - 518.6)

216

466.6 (391.3 - 542.0)

359

550.6 (462.5 - 638.7)

575

515.4 (434.5 - 596.4)

975

P.Phychological

321

873.9 (696.7 - 1051.1)

396

733.3 (472.5 - 994.1)

717

792.3 (571.6 - 1031.1)

498

1074.1 (726.5 - 1241.7)

753

1078.6 (758.1 - 1399.0)

1251

1075.5 (752.5 - 1398.5)

1968

   Depression

42

111.3 (21.4 - 201.3)

115

201.2 (39.9 - 362.6)

157

165.0 (30.3 - 299.7)

141

305.2 (104.7 - 505.7)

282

379.4 (129.9 - 628.9)

423

349.9 (117.5 - 582.2)

580

   Anxiety disorders

77

212.1 (125.1 - 299.0)

68

128.5 (77.6 - 179.3)

145

168.5 (120.5 - 216.5)

115

248.5 (162.9 - 334.2)

116

179.7 (102.9 - 256.5)

231

209.1 (137.1 - 281.2)

376

R.Respiratory

717

1887.6 (1529.3 - 2245.9)

780

1548.0 (1316.7 - 1779.4)

1497

1692.3 (1503.0 - 1881.7)

937

1969.7 (1646.7 - 2292.6)

688

1029.0 (996.3 - 1061.6)

1625

1436.4 (1234.6 - 1638.3)

3122

   Asthma

15

40.6 (20.5 - 60.8)

14

29.6 (4.0 - 55.2)

29

33.9 (16.2 - 51.7)

40

87.4 (58.7 - 116.1)

34

57.4 (23.9 - 90.9)

74

69.4 (41.1 - 97.6)

103

   COPD

71

188.3 (144.1 - 232.5)

326

640.6 (545.9 - 735.4)

397

451.9 (392.7 - 511.0)

79

172.7 (120.8 - 224.7)

230

332.3 (212.0 - 452.5)

309

269.4 (184.3 - 354.5)

706

S.Skin

286

779.3 (671.5 - 887.2)

158

294.2 (208.2 - 380.2)

444

497.1 (429.4 - 564.7)

290

612.7 (526.7 - 698.7)

193

273.2 (178.5 - 367.8)

483

418.0 (330.2 - 505.7)

927

T.Endocrine, metabolic and nutitional

413

1096.5 (941.4 - 1251.5)

1183

2268.6 (2018.8 - 2518.3)

1596

1770.2 (1556.5 - 1983.8)

712

1476.0 (1124.8 - 1827.3)

1750

2525.0 (2214.5 - 2834.5)

2462

2080.4 (1696.6 - 2464.2)

4058

   Lipid disorder

233

620.6 (520.3 - 720.9)

572

1092.5 (1005.7 - 1179.3)

805

892.9 (791.4 - 994.4)

358

723.9 (401.0 - 1046.8)

863

1223.8 (954.8 - 1492.8)

1221

1010.9 (698.7 - 1323.0)

2026

   Diabetes

137

362.6 (282.5 - 442.6)

474

925.3 (774.5 - 1076.0)

611

680.9 (587.1 - 774.6)

208

435.1 (354.1 - 516.1)

653

698.2 (938.8 - 997.6)

861

741.7 (678.9 - 804.4)

1472

U.Urology

96

255.4 (165.0 - 345.8)

131

262.7 (152.0 - 373.4)

227

259.0 (158.2 - 359.8)

140

290.9 (220.6 - 361.1)

178

264.0 (218.4 - 309.7)

318

276.2 (220.0 - 332.5)

545

X.Genital Female

-

-

-

-

-

-

122

261.2 (196.0 - 326.4)

124

179.8 (153.3 - 206.3)

246

217.4 (180.6 - 254.3)

246

Y.Genital male

50

140.3 (96.8 - 183.7)

252

470.4 (373.1 - 567.8)

302

333.9 (254.0 - 413.8)

-

-

-

-

-

 

302

  1. CI: Confidence interval. Estimated prevalence corresponds to each gender and age group and is expressed per 10000 residents